Pathophysiology of Acute Myeloid Leukemia.
Wachter F, Pikman Y.
Acta Haematol. 2024;147(2):229-246. doi: 10.1159/000536152. Epub 2024 Feb 16.
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.
Sperotto A, Bochicchio MT, Simonetti G, Buccisano F, Peccatori J, Piemontese S, Calistri E, Ciotti G, Pierdomenico E, De Marchi R, Ciceri F, Gottardi M.
Biomedicines. 2023 Jan 26;11(2):359. doi: 10.3390/biomedicines11020359.
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia.
Hasserjian RP, Steensma DP, Graubert TA, Ebert BL.
Blood. 2020 May 14;135(20):1729-1738. doi: 10.1182/blood.2019004770.
NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B, Brunetti L, Sportoletti P, Martelli MP.
Blood. 2020 Oct 8;136(15):1707-1721. doi: 10.1182/blood.2019004226.
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.
Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, Payton JE, Kulkarni S, Westervelt P, Walter MJ, Graubert TA, Mardis ER, Wilson RK, DiPersio JF.
Nature. 2012 Jan 11;481(7382):506-10. doi: 10.1038/nature10738.
Clonal haematopoiesis and dysregulation of the immune system.
Belizaire R, Wong WJ, Robinette ML, Ebert BL.
Nat Rev Immunol. 2023 Sep;23(9):595-610. doi: 10.1038/s41577-023-00843-3. Epub 2023 Mar 20.
[Myelofibrosis: A review].
Genthon A, Killian M, Mertz P, Cathebras P, Gimenez De Mestral S, Guyotat D, Chalayer E.
Rev Med Interne. 2021 Feb;42(2):101-109. doi: 10.1016/j.revmed.2020.08.018. Epub 2020 Nov 23.
Clonal Hematopoiesis and Its Impact on Human Health.
Ahmad H, Jahn N, Jaiswal S.
Annu Rev Med. 2023 Jan 27;74:249-260. doi: 10.1146/annurev-med-042921-112347. Epub 2022 Nov 30.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Schmalbrock LK, Dolnik A, Cocciardi S, Sträng E, Theis F, Jahn N, Panina E, Blätte TJ, Herzig J, Skambraks S, Rücker FG, Gaidzik VI, Paschka P, Fiedler W, Salih HR, Wulf G, Schroeder T, Lübbert M, Schlenk RF, Thol F, Heuser M, Larson RA, Ganser A, Stunnenberg HG, Minucci S, Stone RM, Bloomfield CD, Döhner H, Döhner K, Bullinger L.
Blood. 2021 Jun 3;137(22):3093-3104. doi: 10.1182/blood.2020007626.
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments.
Simonsen AT, Meggendorfer M, Hansen MH, Nederby L, Koch S, Hansen M, Rosenberg CA, Kern W, Nyvold CG, Aggerholm A, Haferlach T, Ommen HB.
Exp Hematol. 2022 Mar;107:51-59. doi: 10.1016/j.exphem.2022.01.001. Epub 2022 Feb 3.
